(Q64113812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

1 reference

8 September 2020

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

main subject

immunotherapy

0 references

tumor microenvironment

1 reference

8 September 2020

1 reference

8 September 2020

Felicia Fei-Lei Chung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Chee-Onn Leong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Chun W. Mai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

author name string

Chin-King Looi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Shew-Fung Wong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

Rozita Rosli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

language of work or name

English

0 references

publication date

15 April 2019

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

8 September 2020

Journal of Experimental & Clinical Cancer Research

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

8 September 2020

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

page(s)

162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

3 May 2020

copyright license

1 reference

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

8 September 2020

cites work

1 reference

12 December 2020

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

12 December 2020

Mesothelin is not required for normal mouse development or reproduction

1 reference

12 December 2020

SEREX analysis of gastric cancer antigens

1 reference

12 December 2020

Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.

1 reference

12 December 2020

Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies

1 reference

12 December 2020

Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model

1 reference

12 December 2020

Analysis of the B-cell repertoire against antigens expressed by human neoplasms

1 reference

12 December 2020

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma

1 reference

12 December 2020

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors

1 reference

12 December 2020

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

1 reference

12 December 2020

Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma

1 reference

12 December 2020

Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion.

1 reference

12 December 2020

Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer

1 reference

12 December 2020

Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth

1 reference

12 December 2020

A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers

1 reference

12 December 2020

Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles

1 reference

12 December 2020

Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma

1 reference

12 December 2020

The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens

1 reference

12 December 2020

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

1 reference

12 December 2020

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

1 reference

12 December 2020

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

12 December 2020

Dynamics of the immune reaction to pancreatic cancer from inception to invasion

1 reference

12 December 2020

Mesothelin targeted cancer immunotherapy

1 reference

12 December 2020

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor

1 reference

12 December 2020

Cancer vaccines: accomplishments and challenges

1 reference

12 December 2020

Immunogenic anti-cancer chemotherapy as an emerging concept

1 reference

12 December 2020

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer

1 reference

12 December 2020

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer

1 reference

12 December 2020

Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer

1 reference

12 December 2020

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

1 reference

12 December 2020

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

1 reference

12 December 2020

STATs in cancer inflammation and immunity: a leading role for STAT3

1 reference

12 December 2020

Immunotherapy of human cancers using gene modified T lymphocytes

1 reference

12 December 2020

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

1 reference

12 December 2020

Pancreatic cancer: pathobiology, treatment options, and drug delivery

1 reference

12 December 2020

Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma

1 reference

12 December 2020

Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression

1 reference

12 December 2020

Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

1 reference

12 December 2020

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

1 reference

12 December 2020

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma

1 reference

12 December 2020

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

1 reference

12 December 2020

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation

1 reference

12 December 2020

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

1 reference

12 December 2020

Potential targets for pancreatic cancer immunotherapeutics

1 reference

12 December 2020

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

12 December 2020

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

1 reference

12 December 2020

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

1 reference

12 December 2020

High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer

1 reference

12 December 2020

Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment

1 reference

12 December 2020

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

12 December 2020

Tumor-educated macrophages promote tumor growth and peritoneal metastasis in an orthotopic nude mouse model of human pancreatic cancer.

1 reference

12 December 2020

The pancreas cancer microenvironment

1 reference

12 December 2020

Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

1 reference

12 December 2020

Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives

1 reference

12 December 2020

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

1 reference

12 December 2020

Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance

1 reference

12 December 2020

Agonistic CD40 antibodies and cancer therapy

1 reference

12 December 2020

Impact of tumour associated macrophages in pancreatic cancer.

1 reference

12 December 2020

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

12 December 2020

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

1 reference

12 December 2020

6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).

1 reference

12 December 2020

Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells

1 reference

12 December 2020

Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Deciphering the role of stroma in pancreatic cancer

1 reference

12 December 2020

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer

1 reference

12 December 2020

Signatures of mutational processes in human cancer

1 reference

12 December 2020

Allogeneic tumor cell vaccines: the promise and limitations in clinical trials

1 reference

12 December 2020

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

1 reference

12 December 2020

State of the art in tumor antigen and biomarker discovery.

1 reference

12 December 2020

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

1 reference

12 December 2020

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

1 reference

12 December 2020

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

1 reference

12 December 2020

High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma

1 reference

12 December 2020

A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice

1 reference

12 December 2020

An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.

1 reference

12 December 2020

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

1 reference

12 December 2020

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

1 reference

12 December 2020

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

1 reference

12 December 2020

Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors

1 reference

12 December 2020

Tumor-associated macrophages: from mechanisms to therapy

1 reference

12 December 2020

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

1 reference

12 December 2020

Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment.

1 reference

12 December 2020

Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.

1 reference

12 December 2020

Chimeric antigen receptor T cells for sustained remissions in leukemia

1 reference

12 December 2020

Desmoplasia and chemoresistance in pancreatic cancer

1 reference

12 December 2020

Immuno-oncology combinations: a review of clinical experience and future prospects

1 reference

12 December 2020

PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors

1 reference

12 December 2020

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

1 reference

12 December 2020

Immune escape mechanisms as a guide for cancer immunotherapy

1 reference

12 December 2020

Tumor-associated hyaluronan limits efficacy of monoclonal antibody therapy

1 reference

12 December 2020

Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma

1 reference

12 December 2020

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

1 reference

12 December 2020

T cell exclusion, immune privilege, and the tumor microenvironment

1 reference

12 December 2020

Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015.

1 reference

12 December 2020

Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma.

1 reference

12 December 2020

Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy

1 reference

12 December 2020

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

1 reference

12 December 2020

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

12 December 2020

Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors

1 reference

12 December 2020

Human Tumor Antigens and Cancer Immunotherapy

1 reference

12 December 2020

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

1 reference

12 December 2020

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

1 reference

12 December 2020

Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy

1 reference

12 December 2020

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors

1 reference

12 December 2020

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

1 reference

12 December 2020

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma

1 reference

12 December 2020

Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.

1 reference

12 December 2020

Cancer immunotherapy targeting neoantigens

1 reference

12 December 2020

Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

1 reference

12 December 2020

Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study

1 reference

12 December 2020

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.

1 reference

12 December 2020

Mechanisms Underlying the Anti-Inflammatory Effects of Clinacanthus nutans Lindau Extracts: Inhibition of Cytokine Production and Toll-Like Receptor-4 Activation

1 reference

12 December 2020

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model

1 reference

12 December 2020

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

1 reference

12 December 2020

From bench to bedside a comprehensive review of pancreatic cancer immunotherapy

1 reference

12 December 2020

Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer

1 reference

12 December 2020

Emerging Opportunities and Challenges in Cancer Immunotherapy.

1 reference

12 December 2020

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

1 reference

12 December 2020

Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model

1 reference

12 December 2020

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

1 reference

12 December 2020

Targeting tumor-associated macrophages to combat pancreatic cancer

1 reference

12 December 2020

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

1 reference

12 December 2020

Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade

1 reference

12 December 2020

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

1 reference

12 December 2020

The biology and function of fibroblasts in cancer

1 reference

12 December 2020

Future perspectives in cancer immunotherapy

1 reference

12 December 2020

Pembrolizumab for the treatment of advanced melanoma

1 reference

12 December 2020

Radiotherapy: Changing the Game in Immunotherapy.

1 reference

12 December 2020

Immune checkpoint therapy for pancreatic cancer

1 reference

12 December 2020

Role of immune cells in pancreatic cancer from bench to clinical application: An updated review

1 reference

12 December 2020

PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy

1 reference

12 December 2020

Epidemiology of pancreatic cancer

1 reference

12 December 2020

Targeting legumain as a novel therapeutic strategy in cancers.

1 reference

12 December 2020

Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway

1 reference

12 December 2020

Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.

1 reference

12 December 2020

Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)

1 reference

12 December 2020

Immunotherapy in pancreatic cancer treatment: a new frontier

1 reference

12 December 2020

CAR T-cell therapy for pancreatic cancer.

1 reference

12 December 2020

The role of stromal cancer-associated fibroblasts in pancreatic cancer.

1 reference

12 December 2020

Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions

1 reference

12 December 2020

JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer

1 reference

12 December 2020

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

1 reference

12 December 2020

The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.

1 reference

12 December 2020

Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations

1 reference

12 December 2020

Chemotherapy and tumor microenvironment of pancreatic cancer.

1 reference

12 December 2020

Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.

1 reference

12 December 2020

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

1 reference

12 December 2020

Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.

1 reference

12 December 2020

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

1 reference

12 December 2020

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors

1 reference

12 December 2020

A Bis-benzopyrroloisoquinoline Alkaloid Incorporating a Cyclobutane Core and a Chlorophenanthroindolizidine Alkaloid with Cytotoxic Activity from Ficus fistulosa var. tengerensis

1 reference

12 December 2020

Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.

1 reference

12 December 2020

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

1 reference

12 December 2020

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer

1 reference

12 December 2020

The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.

1 reference

12 December 2020

Drug-like dietary vanilloids induce anticancer activity through proliferation inhibition and regulation of bcl-related apoptotic proteins.

1 reference

12 December 2020

Immunotherapy in Merkel cell carcinoma: role of Avelumab.

1 reference

12 December 2020

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.

1 reference

12 December 2020

Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.

1 reference

12 December 2020

The Immune Revolution: A Case for Priming, Not Checkpoint

1 reference

12 December 2020

The perfect personalized cancer therapy: cancer vaccines against neoantigens.

1 reference

12 December 2020

CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype.

1 reference

12 December 2020

Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC).

1 reference

12 December 2020

Comparative efficacy of vanilloids in inhibiting toll-like receptor-4 (TLR-4)/myeloid differentiation factor (MD-2) homodimerisation

1 reference

12 December 2020

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?

1 reference

12 December 2020

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.

1 reference

12 December 2020

Immunotherapy for pancreatic cancer: Barriers and breakthroughs.

1 reference

12 December 2020

The expansion of targetable biomarkers for CAR T cell therapy

1 reference

12 December 2020

Tumor microenvironment participates in metastasis of pancreatic cancer

1 reference

12 December 2020

Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?

1 reference

12 December 2020

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies.

1 reference

12 December 2020

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

1 reference

12 December 2020

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

1 reference

12 December 2020

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort

1 reference

12 December 2020

FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

1 reference

12 December 2020

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade

1 reference

12 December 2020

The Potential of CAR T Cell Therapy in Pancreatic Cancer

1 reference

12 December 2020

Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy

1 reference

12 December 2020

Alstoscholactine and Alstolaxepine, Monoterpenoid Indole Alkaloids with γ-Lactone-Bridged Cycloheptane and Oxepane Moieties from Alstonia scholaris

1 reference

12 December 2020

A New Molecular Taxonomy to Predict Immune Checkpoint Inhibitor Sensitivity in Prostate Cancer

1 reference

12 December 2020

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches

1 reference

12 December 2020

10.1186/S13046-019-1153-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30987642%20AND%20SRC:MED&resulttype=core&format=json

3 May 2020

PubMed publication ID

30987642

1 reference